Lipoxygenase
Lipoxygenase(脂氧合酶)
Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid. Thre are six LOX isoforms have been found in the humans and mice. 5-Lipoxygenase (5-LOX) is a distinct isoform playing an important role in asthma and inflammation. 5-LOX causes the constriction of bronchioles in response to cysteinyl leukotrienes such as LTC4, thus leading to asthma. 5-LOX also induces neutrophilic inflammation by its recruitment in response to LTB4. 12-Lipoxygenase (12-LOX) is an isoform expressed in epithelial cells and myeloid cells including platelets. 12-LOX can be found in the epithelial cells of the skin. 12-LOX is a potential target for novel anti-platelet therapeutics.15-Lipoxygenase (15-LOX) is expressed in epithelial cells and leukocytes, has different substrate specificity in the humans and mice.15-LOX-1 is a target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
Lipoxygenase 相关产品(254)
- GC12661Indirubin-3'-oximeCAS: 160807-49-8纯度: >99.00%
Inhibitor of GSK3β and cyclin-dependent kinases
- GC18089Nordihydroguaiaretic acidCAS: 500-38-9纯度: >95% / >97.00% / >98.00%
A non-selective LO inhibitor
- GC18552Lipoxin A4CAS: 89663-86-5纯度: >95.00%
Produced by the metabolism of 15-HETE or 15-HpETE with leukocytes
- GC1947413(S)-HpODECAS: 33964-75-9纯度: >95.00%
Stimulates EGF-dependent mitogenesis and tyrosine phosphorylation
- GC26233Docosahexaenoic Acid-d5CAS: 1197205-71-2纯度: >99.00%
Docosahexaenoic acid-d5 (DHA-d5) is intended for use as an internal standard for the quantification of DHA (Item No. 90310) by GC- or LC-MS.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10451 | U-73122 | 112648-68-7 | >98.00% | |
U-73122是有效的、选择性的磷脂酶C(PLC)抑制剂,IC 50 值约为1-2.1μM,也可抑制5-脂氧合酶(5-LO)。 | ||||
| GC10821 | 11-keto-β-Boswellic Acid | 17019-92-0 | >99.50% | |
A 5-LO inhibitor | ||||
| GC12661 | Indirubin-3'-oxime | 160807-49-8 | >99.00% | |
Inhibitor of GSK3β and cyclin-dependent kinases | ||||
| GC14435 | Zileuton sodium | 118569-21-4 | - | |
A reversible inhibitor of 5-lipoxygenase | ||||
| GC14751 | Malotilate | 59937-28-9 | >99.50% | |
A hepatoprotective agent | ||||
| GC14847 | Psoralidin | 18642-23-4 | >98.00% | |
A furanocoumarin with anti-cancer activity | ||||
| GC16014 | Zileuton | 111406-87-2 | >99.00% | |
Zileuton是一种苯并噻吩N-羟基脲类化合物,作为口服5-脂氧合酶抑制剂。 | ||||
| GC18089 | Nordihydroguaiaretic acid | 500-38-9 | >95% / >97.00% / >98.00% | |
A non-selective LO inhibitor | ||||
| GC18480 | CAY10649 | 1272519-89-7 | - | |
A direct inhibitor of 5-LO product formation | ||||
| GC18552 | Lipoxin A4 | 89663-86-5 | >95.00% | |
Produced by the metabolism of 15-HETE or 15-HpETE with leukocytes | ||||
| GC18680 | Lipoxin A4 methyl ester | 97643-35-1 | >95.00% | |
A lipid soluble, prodrug of LXA 4 | ||||
| GC18681 | Lipoxin B4 | 98049-69-5 | >95.00% | |
A positional isomer of LXA 4 | ||||
| GC18688 | CAY10589 | 1077626-52-8 | - | |
Dual Inhibitor of mPGES-1 and 5-LO | ||||
| GC18728 | CJ-13610 | 179420-17-8 | - | |
An inhibitor of 5-LO | ||||
| GC18835 | Leukotriene A4 methyl ester | 73466-12-3 | >97.00% | |
A stable form of LTA 4 | ||||
| GC18845 | Leukotriene F4 | 83851-42-7 | >97.00% | |
A CysLT produced in vitro from LTE 4 | ||||
| GC18877 | CAY10606 | 1159576-98-3 | - | |
Inhibitor of 5-lipoxygenase | ||||
| GC19460 | 9(S)-HODE | 73543-67-6 | >98.00% | |
A lipoxygenase product of linoleic acid | ||||
| GC19462 | 13(R)-HODE | 10219-69-9 | >98.00% | |
An enantiomer of 13(S)-HODE | ||||
| GC19463 | 13(S)-HODE | 29623-28-7 | >98.00% | |
Product of 15-LO metabolism of linoleic acid | ||||
| GC19474 | 13(S)-HpODE | 33964-75-9 | >95.00% | |
Stimulates EGF-dependent mitogenesis and tyrosine phosphorylation | ||||
| GC19933 | Leukotriene B4 | 71160-24-2 | >95.00% | |
A leukotriene involved in inflammation | ||||
| GC26233 | Docosahexaenoic Acid-d5 | 1197205-71-2 | >99.00% | |
Docosahexaenoic acid-d5 (DHA-d5) is intended for use as an internal standard for the quantification of DHA (Item No. 90310) by GC- or LC-MS. | ||||
| GC30027 | S-(+)-Marmesin ((+)-Marmesin) | 13849-08-6 | >98.00% | |
A coumarin with anticancer activity | ||||
